WallStreetZenWallStreetZen

NASDAQ: MEDP
Medpace Holdings Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for MEDP

Based on 8 analysts offering 12 month price targets for Medpace Holdings Inc

Min Forecast
$450.00-24.62%
Avg Forecast
$580.88-2.7%
Max Forecast
$692.00+15.92%

Should I buy or sell MEDP stock?

Based on 8 analysts offering ratings for Medpace Holdings Inc.

Hold
Strong Buy
0 analysts 0%
Buy
2 analysts 25%
Hold
6 analysts 75%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model agrees with analyst consensus with a "Hold" rating. Learn More

Be the first to know when Wall Street analysts revise their MEDP stock forecasts and price targets.

MEDP stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-07-24
lockedlocked$00.00+00.00%2026-07-24
lockedlocked$00.00+00.00%2026-07-24
lockedlocked$00.00+00.00%2026-07-24
lockedlocked$00.00+00.00%2026-07-24
Baird
Top 19%
82
HoldMaintains$624.00+4.53%2026-07-24
Jefferies
Top 16%
85
HoldDowngrades$515.00-13.73%2026-07-07
Barclays
Top 7%
94
HoldMaintains$450.00-24.62%2026-04-24

1 of 1

Forecast return on equity

Is MEDP forecast to generate an efficient return?

Company
151.78%
Industry
384.83%
Market
169.95%
MEDP's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is MEDP forecast to generate an efficient return on assets?

Company
32.01%
Industry
14.99%
MEDP is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

MEDP earnings per share forecast

What is MEDP's earnings per share in the next 3 years based on estimates from 16 analysts?

Avg 1 year Forecast
$17.86+2.82%
Avg 2 year Forecast
$19.61+12.91%
Avg 3 year Forecast
$21.89+26%
MEDP's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

MEDP revenue forecast

What is MEDP's revenue in the next 3 years based on estimates from 16 analysts?

Avg 1 year Forecast
$2.9B+4.48%
Avg 2 year Forecast
$3.1B+10.95%
Avg 3 year Forecast
$3.4B+21.63%
MEDP's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

MEDP earnings growth forecast

How is MEDP forecast to perform vs Diagnostics & Research companies and vs the US market?

Company
7.84%
Industry
18.49%
Market
30.85%
MEDP's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
MEDP's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
MEDP's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

MEDP revenue growth forecast

How is MEDP forecast to perform vs Diagnostics & Research companies and vs the US market?

Company
6.5%
Industry
7.34%
Market
13.49%
MEDP's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
MEDP's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

MEDP vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
MEDP$596.98$580.88-2.70%Hold
CRL$284.37$259.56-8.73%Buy
RVTY$117.88$109.50-7.11%Buy
ICLR$167.17$176.46+5.56%Buy
GH$165.11$181.27+9.79%Strong Buy
View Top Diagnostic & Research Stocks

Medpace Holdings Stock Forecast FAQ

Is Medpace Holdings Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 8 Wall Street analysts covering (NASDAQ: MEDP) stock is to Hold MEDP stock.

Out of 8 analysts, 0 (0%) are recommending MEDP as a Strong Buy, 2 (25%) are recommending MEDP as a Buy, 6 (75%) are recommending MEDP as a Hold, 0 (0%) are recommending MEDP as a Sell, and 0 (0%) are recommending MEDP as a Strong Sell.

If you're new to stock investing, here's how to buy Medpace Holdings stock.

What is MEDP's earnings growth forecast for 2026-2028?

(NASDAQ: MEDP) Medpace Holdings's forecast annual earnings growth rate of 7.84% is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 18.49%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 30.85%.

Medpace Holdings's earnings in 2026 is $491,500,000.On average, 16 Wall Street analysts forecast MEDP's earnings for 2026 to be $498,490,994, with the lowest MEDP earnings forecast at $463,833,092, and the highest MEDP earnings forecast at $525,478,773. On average, 16 Wall Street analysts forecast MEDP's earnings for 2027 to be $547,397,796, with the lowest MEDP earnings forecast at $504,670,634, and the highest MEDP earnings forecast at $587,610,117.

In 2028, MEDP is forecast to generate $610,860,526 in earnings, with the lowest earnings forecast at $559,103,944 and the highest earnings forecast at $662,636,646.

What is MEDP's revenue growth forecast for 2026-2028?

(NASDAQ: MEDP) Medpace Holdings's forecast annual revenue growth rate of 6.5% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 7.34%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.49%.

Medpace Holdings's revenue in 2026 is $2,782,288,000.On average, 16 Wall Street analysts forecast MEDP's revenue for 2026 to be $81,139,181,085, with the lowest MEDP revenue forecast at $76,645,404,630, and the highest MEDP revenue forecast at $84,628,137,960. On average, 16 Wall Street analysts forecast MEDP's revenue for 2027 to be $86,163,278,985, with the lowest MEDP revenue forecast at $79,799,421,645, and the highest MEDP revenue forecast at $93,783,160,800.

In 2028, MEDP is forecast to generate $94,453,040,520 in revenue, with the lowest revenue forecast at $86,163,278,985 and the highest revenue forecast at $103,133,565,225.

What is MEDP's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: MEDP) forecast ROA is 32.01%, which is higher than the forecast US Diagnostics & Research industry average of 14.99%.

What is MEDP's Price Target?

According to 8 Wall Street analysts that have issued a 1 year MEDP price target, the average MEDP price target is $580.88, with the highest MEDP stock price forecast at $692.00 and the lowest MEDP stock price forecast at $450.00.

On average, Wall Street analysts predict that Medpace Holdings's share price could fall to $580.88 by Jul 24, 2027. The average Medpace Holdings stock price prediction forecasts a potential downside of 2.7% from the current MEDP share price of $596.98.

What is MEDP's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: MEDP) Medpace Holdings's current Earnings Per Share (EPS) is $17.37. On average, analysts forecast that MEDP's EPS will be $17.86 for 2026, with the lowest EPS forecast at $16.62, and the highest EPS forecast at $18.83. On average, analysts forecast that MEDP's EPS will be $19.61 for 2027, with the lowest EPS forecast at $18.08, and the highest EPS forecast at $21.05. In 2028, MEDP's EPS is forecast to hit $21.89 (min: $20.03, max: $23.74).

What is MEDP's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: MEDP) forecast ROE is 151.78%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.